Draft Commercial Use Agreement V1C1 template

Adds specs/TargetRevenueCommercialUseAgreement-V1C1.md, the companion
agreement the License repeatedly refers to but never itself set terms
for: commercial entitlement grant, fees and explicit Development Credit
allocation, applicable monetization extensions, metering, audit rights,
term/termination (cross-referenced to License §7.2/§5.2 so a Commercial
Use Agreement termination can never revoke an already-converted Milestone
Release), and a real Section 9 implementing the informed-consent breach-
disclosure election that License §7.4 deferred here: opt-in named
disclosure vs. an anonymized default, a 10-business-day pre-publication
notice with a dispute window, and a data-protection carve-out.

Unlike the License, this Agreement had no dedicated prior-art research
pass (WP-0001 T01-T05 covered license models, terminology, patents,
contributor rights, and jurisdiction constraints, not commercial-agreement
drafting norms) — its preliminary notice says so explicitly, and Appendix A
leaves Section 13 (Indemnification) unwritten rather than guess at a
default carrying real financial exposure.

Corrects three prior references from the placeholder filename
"TRSL-CommercialUseAgreement-Draft.md" to the actual deliverable name, and
cross-references it from README, PRD, TSD, and SCOPE.

Co-Authored-By: Claude Sonnet 5 <noreply@anthropic.com>

specs/TechnicalSpecificationDocument.md

@@ -272,6 +272,7 @@ target-revenue/
 │   ├── TargetLedgerSpecification.md           # WP-0003
 │   ├── MonetizationExtensionSpecification.md  # WP-0003
 │   ├── TargetRevenueSourceLicense-V1C1.md     # WP-0001, ready for human review
+│   ├── TargetRevenueCommercialUseAgreement-V1C1.md  # WP-0001, ready for human review
 │   └── (not yet started:)
 │       ├── CanonicalMonetizationProfiles.md
 │       ├── TargetDegenerationPolicyResearch.md